(Q38125242)

29 August 2017

title

Infectious and noninfectious triggers in Guillain-Barré syndrome (English)

1 reference

29 August 2017

main subject

Guillain–Barré syndrome

0 references

2

Nobuhiro Yuki

1 reference

29 August 2017

Benjamin R Wakerley

1

1 reference

29 August 2017

publication date

1 July 2013

1 reference

Expert Review of Clinical Immunology

29 August 2017

published in

1 reference

29 August 2017

volume

9

1 reference

29 August 2017

issue

7

1 reference

29 August 2017

page(s)

627-639

1 reference

29 August 2017

cites work

Guillain–Barré Syndrome

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

The Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Conduction block in acute motor axonal neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

ROLE OF INFECTION IN THE GUILLAIN-BARR'E SYNDROME

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Clinical and epidemiologic features of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Campylobacter jejuni: molecular biology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Companion animals symposium: microbes and gastrointestinal health of dogs and cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Association between Campylobacter infection and Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Campylobacter jejuni infection and Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome subtypes related to Campylobacter infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

The Guillain-Barré syndrome: a true case of molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Syndromic surveillance for influenzalike illness in ambulatory care network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Ambiguous value of Haemophilus influenzae isolation in Guillain-Barre and Fisher syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Miller Fisher syndrome and Haemophilus influenzae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Neuropsychiatric manifestations of typhoid fever in 959 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome associated with Salmonella paratyphi A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Bickerstaff's brainstem encephalitis complicating Salmonella Paratyphi A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome and influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

How do viral infections predispose patients to bacterial infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

HIV infection presenting with motor axonal variant of Guillain-Barré Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Fisher/Gullain–Barré overlap syndrome in advanced AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

HIV-associated Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Epidemiology and clinical features of HIV-1 associated neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Neuromuscular diseases associated with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Pharmaceutical prescriptions in four European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome after exogenous gangliosides in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Gangliosides and Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Is there a decrease in Guillain-Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Vaccination and autoimmune disease: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Vaccines and Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

An epidemiologic, clinical, and therapeutic study of childhood Guillain-Barré syndrome in Kuwait: is it related to the oral polio vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Analysis of data from the CDC/FDA vaccine adverse event reporting system (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Yellow fever and Japanese encephalitis vaccines: indications and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Reflections on the 1976 swine flu vaccination program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Antibodies to human myelin proteins and gangliosides in patients with acute neuroparalytic accidents induced by brain-derived rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Contamination with gangliosides in brain-derived rabies vaccine may trigger Guillain--Barre syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Systemic lupus erythematosus associated relapsing polyneuropathy: recurrent Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome as presenting feature in a patient with lupus nephritis, with complete resolution after cyclophosphamide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

See no evil, hear no evil, do no evil: the lessons of immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome after rituximab in a patient with idiopathic thombocytopenic purpura: a causal association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Immune-mediated neuropathies in myeloma patients treated with bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

21 January 2018

Tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Tumor necrosis factor-alpha antagonists and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Increased incidence of Guillain-Barré syndrome after surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Clinical review: immunodepression in the surgical patient and increased susceptibility to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Occult herpes family viral infections are endemic in critically ill surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

Overlap of Bickerstaff encephalitis and Guillain-Barré syndrome in a patient with systemic lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.811119

10.1586/1744666X.2013.811119

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference